Literature DB >> 11786729

The CA 125 gene: an extracellular superstructure dominated by repeat sequences.

T J O'Brien1, J B Beard, L J Underwood, R A Dennis, A D Santin, L York.   

Abstract

CA 125 has long presented problems to both clinicians and investigators because there was no definitive information on its structure and function. Here, we describe our work on cloning the CA 125 gene with the anticipation that such information will provide the basis for understanding its structure and its physiologic role in both normal and malignant tissues. The CA 125 protein core is composed of a short cytoplasmic tail, a transmembrane domain and an extraordinarily large glycosylated extracellular structure. This structure is dominated by a repeat domain composed of 156 amino acid repeat units which encompass the epitope binding sites. The molecule also includes an amino terminal domain of serine/threonine-rich sequences which would account for most of the O-glycosylation known to be present in CA 125. CA 125 is an unusually large transmembrane glycoprotein. Its release from the surface of the cell is most probably dependent on cytoplasmic phosphorylation followed by proteolytic cleavage. The extracellular domain is characterized by a large number of repeat units (probably 60+) which encompass an interactive disulfide bridged cysteine-loop and the site of OC125 and M11 binding. Sequencing the gene provides us with the ability to initiate the quest to understand the biological function of CA 125. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11786729     DOI: 10.1159/000050638

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  86 in total

1.  Novel monoclonal antibodies against the proximal (carboxy-terminal) portions of MUC16.

Authors:  Thapi Dharma Rao; Kay J Park; Peter Smith-Jones; Alexia Iasonos; Irina Linkov; Robert A Soslow; David R Spriggs
Journal:  Appl Immunohistochem Mol Morphol       Date:  2010-10

Review 2.  Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells.

Authors:  S Bafna; S Kaur; S K Batra
Journal:  Oncogene       Date:  2010-03-29       Impact factor: 9.867

3.  Identification of unique clusters of T, dendritic, and innate lymphoid cells in the peritoneal fluid of ovarian cancer patients.

Authors:  Jessica Vazquez; Melina Chavarria; Gladys E Lopez; Mildred A Felder; Arvinder Kapur; Antonio Romo Chavez; Nathan Karst; Lisa Barroilhet; Manish S Patankar; Aleksandar K Stanic
Journal:  Am J Reprod Immunol       Date:  2020-06-30       Impact factor: 3.886

4.  MUC16 suppresses human and murine innate immune responses.

Authors:  Mildred Felder; Arvinder Kapur; Alexander L Rakhmilevich; Xiaoyi Qu; Paul M Sondel; Stephen D Gillies; Joseph Connor; Manish S Patankar
Journal:  Gynecol Oncol       Date:  2019-01-06       Impact factor: 5.482

5.  CA125 in ovarian cancer.

Authors:  Nathalie Scholler; Nicole Urban
Journal:  Biomark Med       Date:  2007-12       Impact factor: 2.851

6.  Antibodies Against Specific MUC16 Glycosylation Sites Inhibit Ovarian Cancer Growth.

Authors:  Thapi Dharma Rao; Alberto Fernández-Tejada; Abram Axelrod; Nestor Rosales; Xiujun Yan; Sahityasri Thapi; Amy Wang; Kay J Park; Brandon Nemieboka; Jingyi Xiang; Jason S Lewis; Narciso Olvera; Douglas A Levine; Samuel J Danishefsky; David R Spriggs
Journal:  ACS Chem Biol       Date:  2017-06-28       Impact factor: 5.100

7.  Polymorphisms in the MUC16 gene: potential implication in epithelial ovarian cancer.

Authors:  Houda Bouanene; Hassen Hadj Kacem; Leila Ben Fatma; Halima Ben Limem; Slim Ben Ahmed; Salwa Yakoub; Abdelhédi Miled
Journal:  Pathol Oncol Res       Date:  2010-11-03       Impact factor: 3.201

8.  The epidemiology of CA-125 in women without evidence of ovarian cancer in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial.

Authors:  Christine C Johnson; Bruce Kessel; Thomas L Riley; Lawrence R Ragard; Craig R Williams; Jian-Lun Xu; Saundra S Buys
Journal:  Gynecol Oncol       Date:  2008-06-30       Impact factor: 5.482

9.  A binding domain on mesothelin for CA125/MUC16.

Authors:  Osamu Kaneko; Lucy Gong; Jingli Zhang; Johanna K Hansen; Raffit Hassan; Byungkook Lee; Mitchell Ho
Journal:  J Biol Chem       Date:  2008-12-15       Impact factor: 5.157

10.  Identification and confirmation of biomarkers using an integrated platform for quantitative analysis of glycoproteins and their glycosylations.

Authors:  Yashu Liu; Jintang He; Chen Li; Ricardo Benitez; Sherry Fu; Jorge Marrero; David M Lubman
Journal:  J Proteome Res       Date:  2010-02-05       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.